Actively Recruiting
Exploring the Influence of GLP-1 Medication on Food Attitudes and Selection in a Virtual Reality Buffet
Led by Penn State University · Updated on 2025-09-10
25
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are studying how GLP-1 medications, commonly used to help with weight loss, may change a person's attitudes toward food, their reactions to food, and the types and amounts of foods they choose. The study focuses on adults with overweight or obesity who are starting GLP-1 medication. Understanding these changes can help ensure individuals maintain a balanced nutrient intake while using these medications. Participants will have two visits: one before beginning GLP-1 medication and another three months after starting the medication. No additional treatments or interventions are given between these visits. The study observes participants' food choices and behaviors using a virtual reality buffet to measure changes over time. During the study, researchers will assess changes in the total weight, calories, energy density, and variety of food selected at the virtual buffet from baseline to three months. They will also evaluate changes in food-related questionnaires and craving scores. The participation involves these two visits, with no other treatments or procedures, and will last about three months in total.
CONDITIONS
Brief Title
Identifying Changes in Food Behaviors Associated With Beginning GLP-1 Medication
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults 18 years or older with overweight or obesity (BMI >25 kg/m2)
- Not currently taking an incretin-based medication at baseline
- Recently prescribed a GLP-1 medication within the last two weeks
- May have obesity-related conditions such as diabetes, hypertension, cardiovascular disease, or dyslipidemia
- No prior diagnosis of cognitive or physical disability, dyslexia, or epilepsy
- Fluent in English
You will not qualify if you...
- Adults without overweight or obesity
- Under 18 years of age at time of testing
- Not taking a GLP-1 medication
- Taking a compound GLP-1 medication
- On GLP-1 medication for longer than two weeks at baseline
- Prior diagnosis of cognitive or physical disability, dyslexia, or epilepsy
- Not fluent in English
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 3 months
Participants are observed before starting GLP-1 medication and again 3 months after initiation to assess changes in food behaviors.
1 visit before starting GLP-1 medication and 1 visit 3 months after
Trial Site Locations
Total: 1 location
1
Health, Ingestive Behavior, and Technology Laboratory of Pennsylvania State University
State College, Pennsylvania, United States, 16802
Actively Recruiting
Research Team
C
Christina M Blackmon
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here